TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With

Reinhard Dummer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.